{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:06:48Z","timestamp":1791644808826,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clindermatol.2023.10.010","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T03:49:46Z","timestamp":1697600986000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Conjunctival melanoma: Insights into classification, outcomes, and biomarkers"],"prefix":"10.1016","volume":"42","author":[{"given":"Carol L.","family":"Shields","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria Velasco","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Laiton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Kalafatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Lally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry A.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2023.10.010_bib0001","series-title":"Eyelid, Conjunctival, and Orbital Tumors: An Atlas and Textbook","first-page":"307","author":"Shields","year":"2016"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.survophthal.2003.10.008","article-title":"Tumors of the conjunctiva and cornea","volume":"49","author":"Shields","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0003","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajo.2016.09.034","article-title":"Conjunctival tumors in 5002 cases. Comparative analysis of benign versus malignant counterparts. The 2016 James D. Allen Lecture","volume":"173","author":"Shields","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0004","first-page":"109","article-title":"Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes\u2014the 2017 J. Donald M. Gass Lecture","volume":"6","author":"Shields","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/IOP.0b013e3181a48ad4","article-title":"Conjunctival primary acquired melanosis and melanoma. Tales, fairy tales and facts","volume":"25","author":"Shields","year":"2009","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0006","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0039-6257(97)00122-7","article-title":"Conjunctival melanoma","volume":"42","author":"Seregard","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0007","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ophtha.2007.07.003","article-title":"Primary acquired melanosis of the conjunctiva. Risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman Lecture","volume":"115","author":"Shields","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0008","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0046-8177(85)80061-7","article-title":"Primary acquired melanosis of the conjunctiva","volume":"16","author":"Folberg","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0009","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/bjo.74.10.615","article-title":"Therapeutic outcome of patients suffering from malignant melanoma of the conjunctiva","volume":"74","author":"Lommatzsch PK Lommatzsch","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1755-3768.1992.tb08566.x","article-title":"Conjunctival malignant melanoma in Sweden 1969\u201391","volume":"70","author":"Seregard","year":"1992","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0011","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1167\/iovs.04-0344","article-title":"Conjunctival melanoma in the Netherlands: a nationwide study","volume":"46","author":"Misotten","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0012","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00448801","article-title":"Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population","volume":"234","author":"Norregaard","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0013","first-page":"3399","article-title":"Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites","volume":"43","author":"Tuomaala","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0014","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamaophthalmol.2020.0531","article-title":"Incidence and survival of patients with conjunctival melanoma in Europe","volume":"138","author":"Virgili","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0015","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0002-9394(02)02288-2","article-title":"Conjunctival melanoma: is it increasing in the United States?","volume":"135","author":"Yu","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0016","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.ajo.2003.09.009","article-title":"Conjunctival melanoma: is it increasing in the United States?","volume":"136","author":"Tuomaala","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0017","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/bjo.2009.157933","article-title":"Time trends in the incidence of conjunctival melanoma in Sweden","volume":"93","author":"Triay","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0018","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/IOP.0000000000001624","article-title":"Conjunctival melanoma: features and outcomes based on the Fitzpatrick skin type in 540 patients at a single ocular oncology center","volume":"36","author":"Shields","year":"2020","journal-title":"Ophth Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0019","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ophtha.2010.06.021","article-title":"Conjunctival melanoma. Outcomes based on tumor origin in 382 consecutive cases","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41433-021-01508-y","article-title":"Conjunctival melanoma: outcomes based on tumour origin in 629 patients at a single ocular oncology centre","volume":"36","author":"Pacheco","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0021","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archopht.122.2.167","article-title":"Conjunctival nevi: clinical features and natural course in 410 consecutive patients","volume":"122","author":"Shields","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0022","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.ophtha.2018.02.006","article-title":"Blue nevi of the ocular surface: clinical characteristics, pathological features and clinical course","volume":"125","author":"Sayed-Ahmed","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0023","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archopht.118.11.1581","article-title":"Malignant melanoma arising from unusual conjunctival blue nevus","volume":"118","author":"Demirci","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0024","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.survophthal.2007.10.009","article-title":"Multifocal blue nevus of the conjunctiva","volume":"53","author":"Berman","year":"2008","journal-title":"Survey Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0025","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8033 cases","volume":"32","author":"Shields","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0026","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ophtha.2012.10.021","article-title":"Scleral necrosis following plaque radiotherapy of uveal melanoma: a case-control study","volume":"120","author":"Kaliki","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0027","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archopht.1997.01100150810025","article-title":"Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan lecture","volume":"115","author":"Shields","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0028","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/archopht.118.11.1497","article-title":"Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis and death in 150 consecutive patients","volume":"118","author":"Shields","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0029","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/eye.2008.154","article-title":"An audit of conjunctival melanoma treatment in Liverpool","volume":"23","author":"Damato","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0030","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1177\/1120672120970393","article-title":"Conjunctival melanoma: risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center","volume":"31","author":"Vaidya","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0031","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/bjophthalmol-2020-316293","article-title":"Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study","volume":"105","author":"Jain","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0032","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/ICO.0000000000002449","article-title":"Conjunctival melanoma: outcomes based on age at presentation in 629 patients at a single Ocular Oncology center","volume":"40","author":"Dalvin","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0033","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaophthalmol.2019.1640","article-title":"Multicenter, international assessment of the eighth edition of the American Joint Committee on Cancer staging manual for conjunctival melanoma","volume":"137","author":"Jain","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0034","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/APO.0000000000000343","article-title":"Conjunctival melanoma: outcomes based on the American Joint Committee on Cancer Clinical Classification (8th edition) of 425 patients at a single ocular oncology center","volume":"10","author":"Shields","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0035","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/PAS.0000000000001344","article-title":"Greater tumor thickness, ulceration, and positive sentinel lymph node are associated with worse prognosis in patients with conjunctival melanoma: implications for future AJCC classifications","volume":"43","author":"Esmaeli","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0036","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/IOP.0000000000002238","article-title":"Conjunctival melanoma in 430 cases: comparative analysis of the impact of orbital invasion on tumor recurrence, metastasis, and death","volume":"39","author":"Bas","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0037","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ophtha.2003.11.001","article-title":"Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy","volume":"111","author":"Tuomaala","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0038","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjophthalmol-2018-312018","article-title":"Lack of tumour pigmentation in conjunctival melanoma is associated with light iris colour and worse prognosis","volume":"103","author":"Brouwer","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0039","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00417-019-04342-x","article-title":"Pigmentation of conjunctival melanoma recurrences and outcome","volume":"257","author":"Brouwer","year":"2019","journal-title":"Graefes Arch Clin Exp Ohthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0040","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaophthalmol.2015.3200","article-title":"A retrosspective review of conjunctival melanoma presentation, treatment, and outcoma and an investigation of features associated with BRAF mutations","volume":"133","author":"Larsen","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0041","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ophtha.2022.01.016","article-title":"Mutational landscape and outcomes of conjunctival melanoma in 101 patients","volume":"129","author":"Lally","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0042","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0165-4608(02)00868-3","article-title":"Chromosomal gains and losses in ocular melanoma detected by comparative genomic hybridization in an Australian population-based study","volume":"144","author":"Vajdic","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0043","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-4608(96)00405-0","article-title":"Assessment of chromosome 3 copy number in ocular melanoma using fluorescence in situ hybridization","volume":"98","author":"McNamara","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0044","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1167\/iovs.10-5677","article-title":"Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma","volume":"51","author":"Dratviman-Storobinsky","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0045","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamaophthalmol.2017.2279","article-title":"Pembrolizumab for recurrent conjunctival melanoma","volume":"135","author":"Kini","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0046","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/jamaophthalmol.2020.0522","article-title":"Controlling conjunctival melanoma: to infinity and beyond","volume":"138","author":"Shields","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.010_bib0047","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40257-019-00500-3","article-title":"Conjunctival melanoma: current treatments and future options","volume":"21","author":"Grimes","year":"2020","journal-title":"Am J Clin Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X2300175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X2300175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:21:35Z","timestamp":1760034095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X2300175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0738081X2300175X"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.10.010","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conjunctival melanoma: Insights into classification, outcomes, and biomarkers","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}